Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

MLA

Sorrentino D, et al. “Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab--a Pilot Study.” Digestive Diseases & Sciences, vol. 57, no. 5, May 2012, pp. 1341–48. EBSCOhost, https://doi.org/10.1007/s10620-011-2025-z.

APA

Sorrentino D, Terrosu G, Paviotti A, Geraci M, Avellini C, Zoli G, Fries W, Danese S, Occhipinti P, Croatto T, Zarifi D, Sorrentino, D., Terrosu, G., Paviotti, A., Geraci, M., Avellini, C., Zoli, G., Fries, W., Danese, S., & Occhipinti, P. (2012). Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab--a pilot study. Digestive Diseases & Sciences, 57(5), 1341–1348. https://doi.org/10.1007/s10620-011-2025-z

Chicago

Sorrentino D, Terrosu G, Paviotti A, Geraci M, Avellini C, Zoli G, Fries W, et al. 2012. “Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab--a Pilot Study.” Digestive Diseases & Sciences 57 (5): 1341–48. doi:10.1007/s10620-011-2025-z.